Please login to the form below
Fluarix Quadrivalent
This page shows the latest Fluarix Quadrivalent news and features for those working in and with pharma, biotech and healthcare.
GSK’s four-strain flu vaccine approved in Germany and UK
GSK’ s four-strain flu vaccine approved in Germany and UK. Will be sold as Influsplit Tetra in Germany and Fluarix Tetra in the UK. ... GSK launched its four-strain version in the US last December under the Fluarix Quadrivalent name, and with
Latest news
-
GSK's four-strain flu vaccine debuts in the US
GSK's four-strain flu vaccine debuts in the US. Fluarix Quadrivalent protects against two influenza A and two influenza B subtypes. ... GlaxoSmithKline (GSK) said yesterday the US FDA had approved its four-strain influenza vaccine Fluarix Quadrivalent
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Client Services Director - Med Comms
-
Great salary and bebefits
-
Senior Account Manager
-
Competitive salary commensurate with experience
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Account Manager
-
£40, 000 - £45, 000 benefits
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- Roche keeps Venclexta train rolling with new leukaemia filing
- NHS England says yes to Roche's Hemlibra
- Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices
- Huntsworth buys Giant Creative Strategy
- Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
- Brexit rebels win vote on European Medicines Agency alignment
- Data Visualisation
- The True Potential of Mobile Health Tech
- NHS England to Vertex: come clean on Orkambi offer
PMHub
Market Access Transformation
Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
